Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Work In Process (2016 - 2018)

Historic Work In Process for Amicus Therapeutics (FOLD) over the last 3 years, with Q1 2018 value amounting to $7.2 million.

  • Amicus Therapeutics' Work In Process rose 10745.75% to $7.2 million in Q1 2018 from the same period last year, while for Mar 2018 it was $7.2 million, marking a year-over-year increase of 10745.75%. This contributed to the annual value of $3.8 million for FY2017, which is 1617.29% up from last year.
  • According to the latest figures from Q1 2018, Amicus Therapeutics' Work In Process is $7.2 million, which was up 10745.75% from $3.8 million recorded in Q4 2017.
  • In the past 5 years, Amicus Therapeutics' Work In Process ranged from a high of $7.2 million in Q1 2018 and a low of $137000.0 during Q2 2016
  • For the 3-year period, Amicus Therapeutics' Work In Process averaged around $4.0 million, with its median value being $3.6 million (2017).
  • Over the last 5 years, Amicus Therapeutics' Work In Process had its largest YoY gain of 264306.57% in 2017, and its largest YoY loss of 1617.29% in 2017.
  • Quarter analysis of 3 years shows Amicus Therapeutics' Work In Process stood at $3.3 million in 2016, then increased by 16.17% to $3.8 million in 2017, then soared by 87.48% to $7.2 million in 2018.
  • Its Work In Process was $7.2 million in Q1 2018, compared to $3.8 million in Q4 2017 and $6.9 million in Q3 2017.